- Home
- PRQR vs RFI Comparison
PRQR vs RFI Comparison
Compare PRQR & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- RFI
- Stock Information
- Founded
- PRQR 2012
- RFI 1992
- Country
- PRQR Netherlands
- RFI United States
- Employees
- PRQR N/A
- RFI N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- RFI Investment Managers
- Sector
- PRQR Health Care
- RFI Finance
- Exchange
- PRQR Nasdaq
- RFI Nasdaq
- Market Cap
- PRQR 309.5M
- RFI 311.2M
- IPO Year
- PRQR 2014
- RFI N/A
- Fundamental
- Price
- PRQR $2.67
- RFI $11.75
- Analyst Decision
- PRQR Strong Buy
- RFI
- Analyst Count
- PRQR 5
- RFI 0
- Target Price
- PRQR $7.60
- RFI N/A
- AVG Volume (30 Days)
- PRQR 603.0K
- RFI 69.8K
- Earning Date
- PRQR 11-07-2024
- RFI 01-01-0001
- Dividend Yield
- PRQR N/A
- RFI 8.25%
- EPS Growth
- PRQR N/A
- RFI N/A
- EPS
- PRQR N/A
- RFI N/A
- Revenue
- PRQR $20,506,357.00
- RFI N/A
- Revenue This Year
- PRQR $235.11
- RFI N/A
- Revenue Next Year
- PRQR N/A
- RFI N/A
- P/E Ratio
- PRQR N/A
- RFI N/A
- Revenue Growth
- PRQR 306.68
- RFI N/A
- 52 Week Low
- PRQR $1.61
- RFI $9.62
- 52 Week High
- PRQR $4.62
- RFI $12.52
- Technical
- Relative Strength Index (RSI)
- PRQR 38.02
- RFI 31.50
- Support Level
- PRQR $2.48
- RFI $11.52
- Resistance Level
- PRQR $2.71
- RFI $12.30
- Average True Range (ATR)
- PRQR 0.29
- RFI 0.24
- MACD
- PRQR -0.08
- RFI -0.08
- Stochastic Oscillator
- PRQR 28.09
- RFI 15.86
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.